Appendix 3B - Proposed issue of securities Announcement Summary Entity name IMMURON LIMITED Announcement Type New announcement Date of this announcement 8/1/2025 The Proposed issue is: A placement or other type of issue

Announcement Summary

Date of this announcement

The Proposed issue is:

A placement or other type of issue

Total number of +securities proposed to be issued for a placement

or other type of issue

Proposed +issue date

Refer to next page for full details of the announcement

Part 1 - Entity and announcement details

We (the entity named above) give ASX the following information about

a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis,

we agree to the matters set out in Appendix 3B of the ASX Listing Rules.

If the +securities are being offered under a

+disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued

under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the

final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete

and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation).

1.4 The announcement

1.5 Date of this announcement

1.6 The Proposed issue

A placement or other type of issue

Part 7 - Details of proposed placement or other issue

Part 7A - Conditions

7A.1 Do any external

approvals need to be obtained or other conditions satisfied before the placement or other type of issue can proceed on an unconditional

Part 7B - Issue details

Details of +securities proposed to be issued

ASX +security code and description

Number of +securities proposed to be issued

Are the +securities proposed to

be issued being issued for a cash consideration?

Will these +securities rank equally in all respects from their

issue date with the existing issued +securities in that class?

7C.1 Proposed +issue date

Part 7D - Listing Rule requirements

7D.1 Has the entity obtained, or is it obtaining, +security

holder approval for the entire issue under listing rule 7.1?

7D.1b Are any of the +securities proposed to be issued

without +security holder approval using the entity's 15% placement capacity under listing rule 7.1?

7D.1c Are any of the +securities proposed to be issued

without +security holder approval using the entity's additional 10% placement capacity under listing rule 7.1A (if applicable)?

7D.1c (i) How many +securities are proposed to be

issued without +security holder approval using the entity's additional 10% placement capacity under listing rule 7.1A?

7D.1c (ii) Please explain why

the entity has chosen to do a placement rather than a +pro rata issue or an offer under a +security purchase plan in which existing ordinary

+security holders would have been eligible to participate

Due to the costs and timing benefits of completing the placement.

7D.2 Is a party referred to in listing rule 10.11 participating

in the proposed issue?

7D.3 Will any of the +securities to be issued be +restricted securities

for the purposes of the listing rules?

7D.4 Will any of the +securities to be issued be subject to +voluntary

Part 7E - Fees and expenses

7E.1 Will there be a lead manager or broker to the proposed issue?

7E.2 Is the proposed issue to be underwritten?

7E.4 Details of any other material

fees or costs to be incurred by the entity in connection with the proposed issue

Part 7F - Further Information

7F.01 The purpose(s) for which the entity is issuing the securities

To further research and development

activities and provide on-going working capital.

7F.1 Will the entity be changing its dividend/distribution policy

if the proposed issue proceeds?

7F.2 Any other information the entity wishes to provide about the

7F.3 Any on-sale of the +securities proposed to be issued within

12 months of their date of issue will comply with the secondary sale provisions in sections 707(3) and 1012C(6) of the Corporations Act

The publication of a cleansing notice under section 708A(5), 708AA(2)(f),

1012DA(5) or 1012DAA(2)(f)